Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

BufferGel development assisted by NIH

April 19, 1996

Didanosine + hydroxyurea effective in reducing HIV viral load

April 19, 1996

Ciba-Geigy selects CGP-61755 for development

April 19, 1996

Canada, Brazil approve Invirase for marketing

April 19, 1996

HIV protease inhibitors described by Hoechst Marion Roussel

April 19, 1996

Sankyo claims HIV protease inhibitors

April 19, 1996

Bayer claims anti-HIV quinolone carboxylic acids

April 19, 1996

Cell Genesys to evaluate new gene therapy for AIDS

April 12, 1996

DaunoXome approved as first-line treatment for KS

April 12, 1996

Expanded access for delavirdine initiated

April 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...